H U Group Holdings Inc 4544
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3,770.00
- Day Range
- ¥3,742.00–3,845.00
- 52-Week Range
- ¥2,944.50–3,954.00
- Bid/Ask
- ¥3,817.00 / ¥3,835.00
- Shares Outstanding
- 54.05M
- Market Cap
- ¥206.57B
- Volume/Avg
- 364,200 / 223,311
Key Statistics
- Price/Earnings (Normalized)
- 47.60
- Price/Sales
- 0.86
- Dividend Yield (Trailing)
- 3.27%
- Dividend Yield (Forward)
- 3.27%
- Dividend Payment Schedule
- May, Dec
- Total Yield
- 5.69%
Company Profile
H U Group Holdings Inc is engaged in the contract clinical testing, manufacturing, and sales of clinical diagnostic reagents, and sterilization and surgical-related businesses. Its reportable segments are the Inspection and related services business, the Clinical diagnostic reagent business, and the Healthcare-related services business. It generates the majority of its revenue from the Inspection and related services business segment, which provides comprehensive testing services to medical institutions.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 10,235
- Website
- https://www.hugp.com
Valuation
|
Metric
|
4544
|
|---|---|
Price/Earnings (Normalized) | 47.60 |
Price/Book Value | 1.56 |
Price/Sales | 0.86 |
Price/Cash Flow | 9.08 |
Price/Earnings
4544
Financial Strength
|
Metric
|
4544
|
|---|---|
Quick Ratio | 1.29 |
Current Ratio | 1.76 |
Interest Coverage | 17.84 |
Quick Ratio
4544
Profitability
|
Metric
|
4544
|
|---|---|
Return on Assets (Normalized) | 2.02% |
Return on Equity (Normalized) | 4.05% |
Return on Invested Capital (Normalized) | 2.72% |
Return on Assets
4544
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#<KH#jx | LOCK|@Df | $260B | |||
| Danaher Corp
DHR
| LOCK|sqD%cY%c | LOCK|@C | $165B | |||
| Agilent Technologies Inc
A
| LOCK|$GW$@Ww | LOCK|m<? | $51B | |||
| Waters Corp
WAT
| LOCK|GCRG$>@ | LOCK|?!p | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|fpv^v% | LOCK|!#$^ | $46B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|<x%JdjVv | LOCK|Sn | $44B | |||
| Illumina Inc
ILMN
| LOCK|Q!^qvF | LOCK|m#HpN | $44B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|k#t$<sBv | LOCK|g#p&# | $34B | |||
| Labcorp Holdings Inc
LH
| LOCK|>R>V@%K | LOCK|h#vb | $29B | |||
| Quest Diagnostics Inc
DGX
| LOCK|<X$$nL | LOCK|zdSB | $27B |
United States